InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Flowers Lee. Officer active across 1 company, notably HCW Biologics Inc.. Aggregated, 10 disclosures have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €357k. History available since 22 July 2021. The latest transaction was disclosed on 29 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Flowers Lee is a declarant associated with HCW Biologics Inc., where the only listed role is SVP of Business Development. He has 10 filings in total, and across the sampled recent filings the purchases total 356742 EUR, with no sales, between 2021-07-23 and 2026-07-31, and the modal transaction nature is listed as Acquisition.